|
NOP58 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.636300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.514210E-02 |
| Normal-vs-Stage2 |
6.100000E-02 |
| Normal-vs-Stage3 |
1.114570E-01 |
| Normal-vs-Stage4 |
7.977800E-03 |
| Stage1-vs-Stage2 |
6.014600E-01 |
| Stage1-vs-Stage3 |
6.031400E-01 |
| Stage1-vs-Stage4 |
2.814600E-01 |
| Stage2-vs-Stage3 |
4.050800E-01 |
| Stage2-vs-Stage4 |
8.271600E-01 |
| Stage3-vs-Stage4 |
2.030400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.180290E-02 |
| Normal-vs-AfricanAmerican |
9.161900E-03 |
| Normal-vs-Asian |
8.859200E-01 |
| Caucasian-vs-AfricanAmerican |
1.426190E-01 |
| Caucasian-vs-Asian |
5.516000E-01 |
| AfricanAmerican-vs-Asian |
3.131000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.745800E-02 |
| Normal-vs-Female |
1.237670E-04 |
| Male-vs-Female |
4.100000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.285800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.600120E-02 |
| Normal-vs-Age(61-80Yrs) |
7.255900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.290000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.839200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.059000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.183400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.703800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.214400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.906200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.872350E-02 |
| Normal-vs-Grade 2 |
1.663960E-03 |
| Normal-vs-Grade 3 |
2.084600E-01 |
| Normal-vs-Grade 4 |
7.137100E-03 |
| Grade 1-vs-Grade 2 |
5.750600E-01 |
| Grade 1-vs-Grade 3 |
1.311980E-01 |
| Grade 1-vs-Grade 4 |
7.616400E-01 |
| Grade 2-vs-Grade 3 |
2.022400E-02 |
| Grade 2-vs-Grade 4 |
5.393400E-01 |
| Grade 3-vs-Grade 4 |
4.391500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.613600E-04 |
| Normal-vs-ccB subtype |
4.046800E-01 |
| ccA subtype-vs-ccB subtype |
5.858000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.347600E-02 |
| Normal-vs-N1 |
2.028400E-01 |
| N0-vs-N1 |
4.685600E-01 |
|
|
